Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sitagliptin Treatment in Diabetic COVID-19 Positive Patients: Retrospective Study

NCT04382794 is registered in ClinicalTrials.gov with University of Milan as lead sponsor.

NCT NCT04382794
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04382794 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sitagliptin Treatment in Diabetic COVID-19 Positive Patients: Retrospective Study
Lead sponsor
University of Milan
Phase
Observational
Overall status
Completed
Start date
May 14, 2020
Completion date
June 15, 2020
Enrollment
338 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

covid19